www.impactjournals.com/oncotarget/ Oncotarget, September, Vol.4, No 9 CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia Audrey Astori1,2,3, Hanne Fredly4,5, Thomas Aquinas Aloysius6, Lars Bullinger7, Véronique Mansat-De Mas8,9, Pierre de la Grange10, François Delhommeau11,12, Karen Marie Hagen4,5, Christian Récher8,9, Isabelle Dusanter-Fourt1,2,3, Stian Knappskog6, Johan Richard Lillehaug6, Frédéric Pendino*,1,2,3,6, Øystein Bruserud*,4,5 1 Inserm, U1016, Institut Cochin, F-75014, Paris, France; 2 CNRS, UMR8104, F-75014, Paris, France; 3 Université Paris Descartes, Sorbonne Paris Cité, Paris, France; 4 Section for Hematology, Institute of Medicine, University of Bergen, Norway; 5 Department of Medicine, Haukeland University Hospital; Bergen, Norway; 6 Department of Molecular Biology, University of Bergen, Bergen, Norway; 7 Department of Internal Medicine III, University of Ulm, Ulm, Germany; 8 Inserm, Unité Mixte de Recherche 1037-Cancer Research Center of Toulouse, CNRS 5294, Université de Toulouse, Centre Hospitalier Universitaire Purpan, F-31059, Toulouse, France; 9 Service d’Hématologie, Centre Hospitalier Universitaire Purpan, Hôpital Purpan, F-31059, Toulouse, France; 10 GenoSplice, Hôpital Saint-Louis, F-75010, Paris, France; 11 UPMC, Pierre and Marie Curie University, GRC n°07, Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MyPAC, F-75012, Paris, France; 12 AP-HP, Hôpital Saint-Antoine, Service d’Hématologie et Immunologie Biologiques, F-75012, Paris, France. * These two authors shared the last authorship. Correspondence to: Frédéric Pendino, email:
[email protected] Keywords: Acute myeloid leukemia, CXXC5/RINF, chemotherapy, apoptosis Received: July 30, 2013 Accepted: August 13, 2013 Published: August 15, 2013 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.